Concepedia

Chih-Hung Hsu

CH

Statistics

Publications

1

Citations

57

H-Index

1

Active since

2025

Affiliations

Roche (China)(Current)

Chih-Hung Hsu is an author at Roche (China) specializing in metastatic hepatocellular carcinoma, immune checkpoint regulation, and immunotherapy.

Publications per year

2025–2025

1

Publications

1

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study

Richard Finn, Baek‐Yeol Ryoo, Chih-Hung Hsu et al. · The Lancet Oncology · 2025 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–1 of 1